Consolidated Statement of Comprehensive Income

Profit after tax

188.7

227.2

303.3

481.9

Available-for-sale financial assets

Fair value adjustments

1.1

–3.2

1.2

26.1

Reclassification to income statement

–

0.2

–

–27.0

Deferred taxes

–

0.8

–

1.4

Changes recognized in equity

1.1

–2.2

1.2

0.5

Derivative financial instruments

Fair value adjustments

7.9

–45.8

–43.1

–32.6

Reclassification to income statement

10.7

–3.2

65.0

–6.8

Deferred taxes

–3.0

7.8

–1.8

7.6

Changes recognized in equity

15.6

–41.2

20.2

–31.8

Remeasurement of the net defined benefit liability

Changes in remeasurement

–97.1

–2.0

–106.9

–

Deferred taxes

16.6

0.8

14.7

0.9

Changes recognized in equity

–80.5

–1.2

–92.2

0.9

Exchange differences on translating foreign operations

Changes taken directly to equity

–8.6

–32.7

33.4

–75.1

Reclassification to income statement

–

–

–

3.5

Changes recognized in equity

–8.6

–32.7

33.4

–71.6

Gains/losses recognized immediately in equity

–72.4

–77.3

–37.4

–102.0

Comprehensive income

116.4

149.9

265.9

379.9

of which attributable to Merck KGaA shareholders

112.5

146.2

258.0

374.4

of which attributable to non-controlling interest

3.9

3.7

7.9

5.5